norfloxacin has been researched along with framycetin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Arroyo, V; Ginès, A; Ginès, P; Llach, J; Mas, A; Navasa, MA; Rimola, A; Rodés, J; Salmerón, JM; Titó, L | 1 |
Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
Toorop-Bouma, AG; Van der Waaij, D | 1 |
Frimodt-Møller, PC; Jensen, KM; Madsen, PO | 1 |
Cumsille, F; Defilippi, C; Hurtado, C; Madrid, AM; Venegas, M | 1 |
Adhikary, A; Biswal, S; Chatterjee, D; Ghosh, AS | 1 |
2 trial(s) available for norfloxacin and framycetin
Article | Year |
---|---|
Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure.
Topics: Adult; Bacterial Infections; Colistin; Enterobacteriaceae; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hepatic Encephalopathy; Humans; Liver Diseases; Male; Neomycin; Norfloxacin; Nystatin; Pregnancy | 1992 |
Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cisapride; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Norfloxacin; Severity of Illness Index; Time Factors | 2001 |
7 other study(ies) available for norfloxacin and framycetin
Article | Year |
---|---|
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin | 1985 |
The effect of selective decontamination of the gi-tract of mice on the survival of intestinal mucosa during X-irradiation.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Colon; Digestive System; Female; Gram-Negative Bacteria; Ileum; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Nalidixic Acid; Neomycin; Norfloxacin | 1985 |
Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Digestive System; Drinking; Feces; Nalidixic Acid; Neomycin; Norfloxacin; Rats; Rats, Inbred Strains | 1983 |
A NiCoT family metal transporter of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cobalt; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Ethambutol; Gentamicins; Isoleucine; Isoniazid; Kanamycin; Leucine; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Neomycin; Nickel; Norfloxacin; Ofloxacin | 2022 |